Does the AT2-receptor mediate anti-atherosclerotic actions?
Ulrich
U
Kintscher
Thomas
T
Unger
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001053:Apolipoproteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism*; D001794:Blood Pressure; D002791:Cholesterol, Dietary / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D011725:Pyridines / Q000494:pharmacology; D044139:Receptor, Angiotensin, Type 2 / Q000235:genetics / Q000378:metabolism*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D001053:Apolipoproteins; D002791:Cholesterol, Dietary; D007093:Imidazoles; D011725:Pyridines; D044139:Receptor, Angiotensin, Type 2; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; C073402:PD 123319